Patents by Inventor Gordon Santesson

Gordon Santesson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulation
    Patent number: 6986904
    Abstract: A new metered unit dose comprising 40 ?g or less of budesonide is disclosed as well as a formulation thereof and the use thereof for the treatment of conditions in the nose.
    Type: Grant
    Filed: November 17, 2003
    Date of Patent: January 17, 2006
    Assignee: AstraZeneca AB
    Inventors: Hans Nilsson, Gordon Santesson
  • Novel formulation
    Publication number: 20040101486
    Abstract: A new metered unit dose comprising 40 &mgr;g or less of budesonide is disclosed as well as a formulation thereof and the use thereof for the treatment of conditions in the nose.
    Type: Application
    Filed: November 17, 2003
    Publication date: May 27, 2004
    Inventors: Hans Nilsson, Gordon Santesson
  • Formulation
    Patent number: 6686346
    Abstract: A new metered unit dose comprising 40 &mgr;g or less of budesonide is disclosed as well as a formulation thereof and the use thereof for the treatment of conditions in the nose.
    Type: Grant
    Filed: August 20, 2001
    Date of Patent: February 3, 2004
    Assignee: Astra Aktiebolag
    Inventors: Hans Nilsson, Gordon Santesson
  • Dry powder pharmaceutical formulation
    Patent number: 6391340
    Abstract: There is described a solid particulate pharmaceutical formulation suitable for application to the nose comprising finely divided additive particles and finely divided drug particles, wherein the mass median diameter of the drug particles is greater than that of the additive particles.
    Type: Grant
    Filed: February 24, 2000
    Date of Patent: May 21, 2002
    Assignee: AstraZeneca AB
    Inventors: Karin Malmqvist-Granlund, Gordon Santesson, Eva Trofast
  • Novel formulation
    Publication number: 20020016315
    Abstract: A new metered unit dose comprising 40 &mgr;g or less of budesonide is disclosed as well as a formulation thereof and the use thereof for the treatment of conditions in the nose.
    Type: Application
    Filed: August 20, 2001
    Publication date: February 7, 2002
    Applicant: Astra Aktiebolag, a Swedish corporation
    Inventors: Hans Nilsson, Gordon Santesson
  • Low dose budesonide formulations and uses thereof
    Patent number: 6291445
    Abstract: A metered unit dose comprising 40 &mgr;g or less of budesonide is disclosed, as well as formulations thereof, and the use thereof for the treatment of nasal conditions.
    Type: Grant
    Filed: April 29, 1997
    Date of Patent: September 18, 2001
    Assignee: Astra Aktiebolag
    Inventors: Hans Nilsson, Gordon Santesson